Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
about
Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for InfectionViral entry pathways: the example of common cold virusesApplications of CRISPR-Cas systems in neuroscienceEnabling functional genomics with genome engineeringPatterns of CRISPR/Cas9 activity in plants, animals and microbesHunting Viral Receptors Using Haploid CellsEpithelial magnesium transport by TRPM6 is essential for prenatal development and adult survivalA CRISPR toolbox to study virus-host interactionsUnraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.Applications of the CRISPR-Cas9 system in cancer biology.Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.A versatile reporter system for CRISPR-mediated chromosomal rearrangements.Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells.Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome.Genome Editing with CRISPR-Cas9: Can It Get Any Better?Increasing the performance of pooled CRISPR-Cas9 drop-out screening.Efficient generation and reversion of chromosomal translocations using CRISPR/Cas technology.Massively multiplex single-cell Hi-C.Functional interrogation of non-coding DNA through CRISPR genome editing.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisCRISPR-STAT: an easy and reliable PCR-based method to evaluate target-specific sgRNA activity.Direct α-synuclein promoter transactivation by the tumor suppressor p53.An alternative strategy for targeted gene replacement in plants using a dual-sgRNA/Cas9 design.Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system.A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular ResearchPlatelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus MutantsLoss-of-function genetic tools for animal models: cross-species and cross-platform differences.Vector Integration Sites Identification for Gene-Trap Screening in Mammalian Haploid Cells.Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase.High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges.CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.Generation of apoptosis-resistant HEK293 cells with CRISPR/Cas mediated quadruple gene knockout for improved protein and virus production.Robust long-read native DNA sequencing using the ONT CsgG Nanopore system.Position-effect variegation revisited: HUSHing up heterochromatin in human cells.Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.Systematic identification of genes involved in metabolic acid stress resistance in yeast and their potential as cancer targets.Parallel reverse genetic screening in mutant human cells using transcriptomicsA generic strategy for CRISPR-Cas9-mediated gene tagging.
P2860
Q26748980-23388025-CD1B-4E95-8002-D568482A221EQ26750146-3D9EC898-E31F-4329-958A-3169A75E3CA6Q26776515-A1267A13-86A1-4D59-B174-4A2EB9E8E3E3Q26782747-930AEBE1-FA3F-4191-86C0-8E34990F7BBCQ28078150-1551F082-A069-4EF9-9815-F80823E5F6C0Q28080327-C219DA07-B0CC-40BE-8F42-02365DEC685CQ28817847-C70C7CAA-FC10-4DFE-80FF-F3C70DF5A121Q29994612-4C2DCF58-2F7C-4315-9FBE-3E407143B5D6Q30241067-2D93DB1A-8574-4B23-858A-9D7FA91BD313Q34479139-77EED327-41F4-4F24-8238-FD37C1C0C723Q35686057-BCF4F906-9220-4F5C-A500-52CE8D510079Q35734029-E49A275A-29CA-4EE9-AD09-192ADC28F1BEQ35920105-BDDE94F2-D373-40B7-BC49-49F0B4612422Q35968059-519DA663-9D80-4F95-B868-139701CC46B2Q36002378-B5149187-C79A-4023-8664-02A96E956CEBQ36025657-BA8BC02F-6A5C-4129-AFAE-4C0E5E40B1D2Q36108527-26F84F27-F118-4D57-BBC4-C9912D9149B0Q36136571-438C5708-C9C8-491B-B6B1-A65375513A67Q36263741-45A86E9F-6837-42EA-9E63-7618B8B54093Q36306820-9850BCEC-B092-4E9D-96E2-77B4DC35D56DQ36367103-A5846090-2E26-406E-95AB-599563039569Q36370882-F86D3656-2CB7-4C86-9AB6-122031457150Q36531366-F38A406F-7B7F-456A-A72B-A442E6D99772Q36754951-3C829295-3BFB-47C9-8625-AB964C1D51D3Q36882721-6EE923C1-64B9-4D19-A7AB-FE782CBD9A6AQ36940626-4DCF7352-9FE6-4978-A598-0E1DC2FDD071Q37032510-6714D3FE-3128-4085-82D2-97288973CA82Q37182678-5C9CE3E4-29CD-43FC-85C8-4A1404780F14Q37550614-E66C0100-903F-4191-B1F1-8BCB635506B7Q37708200-A2420E83-3B43-4E47-AD87-01A783EF43E2Q37737116-BD64D4D8-8378-4D7D-9512-E9948BAEC18FQ38498286-C9BA6652-BFAE-46A5-AB5B-A5AD8DD4AB2AQ38522356-C2E2DC37-052C-4518-8970-050FABC853B0Q38697280-EEB04C37-8219-404B-BA9F-7DA55E70D7C2Q38703563-626A6A51-35A5-4A1C-8227-E7532E1FC4F8Q38725574-2E002FF1-8F65-4DE2-9D72-1479678C66B3Q38733510-725D1F42-3CA2-4B4C-8297-EB477D84C45AQ38752235-AB1A162D-6A2D-49F9-90CD-4B12C1D844FCQ38754311-A4FB6574-5D8E-4392-B478-95C63989D28DQ38811370-B5DB872B-F75E-4655-828B-148B4A5818EB
P2860
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@ast
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@en
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@nl
type
label
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@ast
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@en
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@nl
prefLabel
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@ast
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@en
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@nl
P2093
P2860
P4510
P50
P356
P1433
P1476
Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.
@en
P2093
Bianca V Gapp
Doris Chen
Federica Santoro
Thijn R Brummelkamp
Tilmann Bürckstümmer
Tomasz Konopka
P2860
P304
P356
10.1101/GR.177220.114
P577
2014-11-04T00:00:00Z